Connect with us

Hi, what are you looking for?

CE Mark

Innovative Health Sciences Wins CE mark for Syringe Infusion System

Innovative Health Sciences announced today that it received CE mark approval in Europe for its Insignis syringe infusion system.

Innovative Health Sciences Wins CE mark for Syringe Infusion System

Innovative Health Sciences announced today that it received CE mark approval in Europe for its Insignis syringe infusion system.

Chester, N.Y.-based Innovative Health Sciences designed the Insignis syringe infusion system to offer a combination of intravenous and subcutaneous non-electric infusion for use with a selectable rate flow controller — the IV Controller and the OneSett.

According to a news release, the newly CE-marked system — which also garnered ISO 13485 quality management system certification — is the first combination of such infusion methods.

Insignis, used for intravenous administration, creates a portable, non-electric, versatile, cost-effective and intuitive infusion pump option, Innovative Health Sciences said. The system accurately delivers medications from KVO up to 250mL/hour with a direct reading selectable rate flow controller.

The company said Insignis will be offered at €139 (approximately $163.91), with the OneSett offering lower cost per infusion, considering the cost of separate pieces of the ancillary supplies.

“The IHS system represents a paradigm shift in simplicity, excellence, cost effectiveness, usability and patient-centered design,” Innovative Health Sciences founder, chairman & CTO Andrew Sealfon said in the release

The post Innovative Health Sciences wins CE mark for syringe infusion system appeared first on Drug Delivery Business.

Seen on Drug Delivery Business: Article Link

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Latest News

Diagnostics

PocDoc, the digital health platform and personal diagnostics provider, has launched what it says is a world-first smartphone-based test for cardiovascular disease.

HealthTech

Focused on connecting startups in the Medtech industry with potential investors, this can't miss event features the globe's most promising companies

BioTechnology

The technology could greatly aid spinal surgeons in planning surgical interventions in advance.   

Exclusives

Emerging HealthTech company, Stasis Labs, Inc. intends to bridge the gap between clinicians and their patients with an all-in-one FDA-cleared hardware and software solution,...

You May Also Like

Exclusives

Today & Tomorrow: Digital Solutions in HealthTech Plug “digital healthcare solutions” into Google, and the results are clear: digital tools have taken the healthcare...

Exclusives

In Delray Beach, Florida, an emerging biopharma company, Cyrano Therapeutics, is planning a clinical trial using approved theophylline via a new intranasal pathway of...

Exclusives

Software as a Medical Device (SaMD) is driving innovation in the HealthTech space and is more popular than ever — completely upending the way...

Exclusives

The sky’s the limit for HealthTech PR and looking past traditional strategies to nontraditional avenues for engagement will allow agencies to stand out.